The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5

Area of Science:

• Immunology
• Cell Biology
• Developmental Biology

Background:

• Innate lymphocytes, specifically IL-17-producing RORγt+ γδ T cells (γδT17 cells), are key players in type 3 immune responses during infection and inflammation.
• Understanding the developmental pathways of these cells is critical for modulating immune responses in disease contexts.

Purpose of the Study:

• To investigate the role of STAT5 signaling in the neonatal development and tissue imprinting of γδT17 cells.
• To determine the impact of γδT17 cell populations on autoimmune disease models.

Main Methods:

• Conditional STAT5 deficiency in mice.
• Analysis of γδT17 cell proliferation, cytokine expression (IL-17, IL-22, IFN-γ), and transcription factor expression (T-bet) in neonatal and adult organs.
• Assessment of experimental autoimmune encephalomyelitis (EAE) in mice with altered γδT17 cell numbers.

Main Results:

• Neonatal γδT17 cell expansion is dependent on STAT5, with STAT5A playing a dominant role over STAT5B in promoting γδT17 cell expansion and downregulating T-bet.
• STAT5 deficiency leads to γδT17 cell depletion and profound resistance to experimental autoimmune encephalomyelitis.
• STAT5B preferentially expands IFN-γ-producing γδ populations, indicating distinct roles for STAT5 gene products.

Conclusions:

• The neonatal microenvironment and STAT5 signaling are critical for post-thymic γδT17 cell development and tissue-specific imprinting.
• STAT5-mediated regulation of γδT17 cells is essential for both susceptibility to autoimmunity and defense against infection.
• Targeting STAT5 signaling could offer a therapeutic strategy for autoimmune diseases.